Impact of adenosine diphosphate and calcium chelation on platelet aggregation testing in patients receiving clopidogrel therapy [1]

Journal of the American College of Cardiology

Volumn 47, Issue 2, 2006, Pages 464-465

  Patel, Paraj ^b   Gonzales, Rafael ^b   Dokainish, Hisham ^b   Lakkis, Nasser ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHELATING AGENT; CITRATE TRISODIUM; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SIMVASTATIN;

ADULT; ANALYSIS OF VARIANCE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; FEMALE; HUMAN; HUMAN CELL; LETTER; MALE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; AMINO ACID CHLOROMETHYL KETONES; CHELATING AGENTS; CITRATES; CORONARY DISEASE; CYSTEINE PROTEINASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; TICLOPIDINE;

EID: 30344438281     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.10.032     Document Type: Letter

References (5)

1. CAPRIE Steering Committee A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) Lancet 348 1996 1329 1339
2. S. Yusuf, F. Zhao, S.R. Mehta Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
3. S.R. Steinhubl, P.B. Berger, J.T. Mann Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention a randomized control trial JAMA 288 2002 2411 2420
4. M.A. Packham, N.L. Bryant, M.A. Guccione Effect of the concentration of Ca in the suspending medium on the responses of human and rabbit platelet to aggregating agents Thromb Haemost 62 1989 968 976
5. S.R. Steinhubl, J.D. Talley, G.A. Braden Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention results of the GOLD (AU-Assessing Ultegra) multicenter study Circulation 103 2001 2572 2578